Browse by Industry
Filter News
Found 35,204 articles
-
Eli Lilly and Company, headquartered in Indianapolis, and AC Immune SA, based in Lausanne, Switzerland, entered a license and collaboration deal to research and develop tau aggregation inhibitor compounds for the treatment of Alzheimer’s and other neurodegenerative diseases.
-
The Boston area, specifically Cambridge, has the highest concentration of biopharma companies in the U.S. That is followed rather closely by the San Francisco Bay Area. Many states want to encourage life science development—the return on investment can be very high, and the jobs they create are o...
-
Microsoft co-founder Paul Allen set aside $125 million to fund a new division at a scientific institute he founded to focus on understanding the immune system. This morning, it was reported that the Allen Institute is expanding.
-
Tremfya was being compared to Novartis’ Cosentyx (secukinumab) in a head-to-head study. In the trial, Tremfya showed that 84.5 percent of patients treated with the drug achieved at least 90 percent improvement in their baseline Psoriasis Area Severity Index (PASI) score at 48 weeks.
-
More pharma workers in France are receiving coal in their stockings this year after Germany-based Boehringer Ingelheim announced plans to cut about 300 jobs in that country as part of a reorganization of its operations in France.
-
The rejection comes about a month after the painkiller was cleared by an FDA advisory committee.
-
Lawsuit Charges FDA, NIH With Failing to Follow Established Law for Reporting of Clinical Trial Data
12/12/2018
The lawsuit alleges that the government is letting a number of researchers off the hook of reporting clinical data. -
Bausch Health Companies is acquiring basically all of Synergy Pharmaceuticals’ assets, including all rights to Trulance (plecanatide), dolcanatide and related intellectual property.
-
Yesterday, the agency and Gottlieb doubled-down on the Action Plan and added to it. The FDA released two new draft Q&A guidance documents on biosimilar development and two final guidance documents on the same topics, as well as a proposed amendment to the definition of a biological product.
-
CAP Files Legal Brief Supporting Challenge to Correct Scheme for Setting Medicare Fees for Clinical Laboratory Tests
12/12/2018
The CAP argues the administration failed to follow congressional intent when establishing market-based payment reforms for clinical laboratory services.
-
Geneva Health Solutions Hits Critical Milestones Driving Growth; Predicts Cardiac Data Explosion in 2019
12/12/2018
Geneva Health Solutions (GHS), the leading cloud-based technology platform and service for managing data from implantable cardiac devices, announces triple-digit revenue growth in 2018, an indicator of the explosive growth of implantable cardiac device data expected in 2019.
-
Adaptive Phage Therapeutics Enters into Collaboration Agreement with Researchers at Yale University to Manufacture and Supply Therapeutic Bacteriophage
12/12/2018
Adaptive Phage Therapeutics, Inc. (APT), a clinical-stage biotechnology company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria, today announced it has entered into a collaboration agreement with the Paul Turner Lab at Yale University to manufacture and supply therapeutic bacteriophage (phage) for use in clinical trials.
-
16S Next Generation Sequencing Bacterial Meningitis test from Viracor Eurofins provides actionable results to improve patient outcomes
12/12/2018
Viracor Eurofins announced the recent launch of a new 16S Next Generation Sequencing (NGS) Bacterial Meningitis test for use in patients suspected of having bacterial meningitis.
-
Brigham Young University Makes History, Sets New World Record in Bayer Alka-Rocket Challenge
12/12/2018
Brigham Young University student rocketeers blasted their way into history today, setting a new GUINNESS WORLD RECORDS title for Highest launch of an Alka-Rocket* in the 2018 Bayer Alka-Rocket Challenge.
-
CarThera closes €9M ($10.3M) Series B funding round
12/12/2018
CarThera, a French company that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today announces that it has closed its Series B funding round
-
Bovie Medical Corporation Announces Corporate Name Change to Apyx Medical Corporation and Plans to Transition Common Stock Listing to NASDAQ Global Select Market
12/12/2018
Bovie Medical Corporation (NYSE:BVX) (the “Company”), a maker of medical devices and supplies and the developer of J-Plasma®, a patented surgical product marketed and sold under the Renuvion® Cosmetic Technology brand in the cosmetic surgery market, today announced a corporate rebranding and company name change to Apyx Medical Corporation effective January 1, 2019.
-
Arizona State University selected to innovate military health care logistics; ASU awarded $2.4 million grant to fund DoD research project
12/12/2018
The W. P. Carey School of Business at Arizona State University today announced plans to provide strategic recommendations to the nation's military to improve patient care for service members.
-
Minister Jody Wilson-Raybould and Minister Ginette Petitpas Taylor Table in Parliament the Independent Reviews Related to Medical Assistance in Dying
12/12/2018
The Honourable Jody Wilson-Raybould, Minister of Justice and Attorney General of Canada, and the Honourable Ginette Petitpas Taylor, Minister of Health, issued the following statement:
-
Outcomes of weight loss surgery can be improved
12/12/2018
Lower BMI before bariatric surgery predicts greater post-operative weight loss, a new study from the University of Eastern Finland finds.
-
Avacta Appoints Dr Jose Saro as Chief Medical Officer
12/12/2018
Dr Jose Saro joins Avacta from Roche to lead the Group’s Affimer® therapeutic development strategy and drive the in-house programmes into the clinic